Clinical Research

For more information on review board and clinical research please click here to download a PDF.

The following protocols are currently open for enrollment:

Oncology Clinical Trials

Please contact your physician or Nancy Dye, RN, CCRP, Oncology Program Coordinator at 681-342-1804 for more information.

For more information on review board and clinical research please click here.

Principal Investigator – Dr. Paul Brager

NSABP B43

A Phase III Clinical Trial comparing trastuzumab given concurrently with radiation therapy and radiation therapy alone for women with HER-2 positive DCIS resected by lumpectomy

NSABP B47

A Randomized Phase III Trial of adjuvant therapy comparing chemotherapy alone (six cycles of docetaxel plus cyclophosphamide or four cycles of docorubicin plus cyclophosphamide followed by weekly paclitaxel) to chemotherapy plus trastusumab in women with node positive or high risk node negative HER-2 low invasive breast cancer

NSABP P5

Statin polyp prevention trial in patients with resected colon cancer

CALGB 80702

A phase III trial of 6 versus 12 treatments of adjuvant FOLFOX plus celecoxib or placebo for patients with resected stage III colon cancer

Cardiology Clinical Trial

JOMED (JOSTENT) Coronary Stent Graft

Principal Investigator – Dr. Gerardo Lopez

Surgical Clinical Trial

Gastric Electrical Stimulation (Enterra)

Principal Investigator – Dr. Jeffrey Madden

Orthopaedics Clinical Trial

Proximal Interphalangeal Joint

Principal Investigator – Dr. Gerald Farber